CVR number 18973871
Industry 75.0000 Veterinary activities

KASERNEN'S HESTEKLINIK A/S

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.5% 2.6% 1.6% 1.6% 1.2%  
Credit score (0-100)  64 63 75 73 81  
Credit rating  BBB BBB A A A  
Credit limit (kDKK)  0.0 0.0 8.5 12.0 109.7  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Net sales  0 0 0 0 0  
Gross profit  4,454 4,929 5,487 6,737 6,431  
EBITDA  420 515 571 1,994 1,465  
EBIT  110 205 322 1,809 1,362  
Pre-tax profit (PTP)  95.7 198.4 313.7 1,795.7 1,343.4  
Net earnings  74.2 154.1 235.5 1,401.5 1,068.6  
Pre-tax profit without non-rec. items  95.7 198 314 1,796 1,343  
 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Tangible assets total  725 446 378 232 130  
Shareholders equity total  1,082 1,236 1,471 2,305 2,074  
Interest-bearing liabilities  125 25.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,075 2,228 2,641 3,917 3,533  
Net Debt  -81.0 -999 -1,277 -2,693 -2,351  
 
See the entire balance sheet

Volume 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,454 4,929 5,487 6,737 6,431  
Gross profit growth  -5.6% 10.7% 11.3% 22.8% -4.6%  
Employees  6 6 6 6 6  
Employee growth %  -14.3% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,075 2,228 2,641 3,917 3,533  
Balance sheet change%  -11.7% 7.4% 18.5% 48.3% -9.8%  
Added value  420.5 515.3 571.1 2,057.8 1,464.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -620 -589 -317 -331 -204  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  2.5% 4.2% 5.9% 26.9% 21.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  5.0% 9.5% 13.2% 55.2% 36.6%  
ROI %  8.2% 15.8% 22.5% 93.0% 62.2%  
ROE %  7.1% 13.3% 17.4% 74.2% 48.8%  

Solidity 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Equity ratio %  52.1% 55.5% 55.7% 58.9% 58.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -19.3% -193.8% -223.6% -135.0% -160.5%  
Gearing %  11.6% 2.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  11.7% 9.0% 68.7% 0.0% 0.0%  

Liquidity 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Quick Ratio  1.1 1.4 1.8 2.1 2.1  
Current Ratio  1.5 1.8 2.1 2.3 2.3  
Cash and cash equivalent  206.0 1,023.6 1,277.1 2,692.8 2,351.2  

Capital use efficiency 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  437.5 761.5 1,166.1 2,031.2 1,902.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2018/9
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
Net sales / employee  0 0 0 0 0  
Added value / employee  70 86 95 343 244  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  70 86 95 332 244  
EBIT / employee  18 34 54 302 227  
Net earnings / employee  12 26 39 234 178